What the Rybelsus® documents list
Searching the three documents for muscle or joint pain finds nothing. The entries that come closest describe the skin and a laboratory value rather than aches in muscles or joints.
| Document | Entry | Detail |
|---|---|---|
| EU summary, section 4.8 [2] | Dysaesthesia: common | Based on 25 and 50 mg; no imbalance at 3, 7 and 14 mg; mild to moderate, most recovered on treatment |
| US Prescribing Information, section 6.2 [1] | Dysesthesia | Postmarketing report, no rate |
| Canadian Product Monograph, section 8.5 and patient information [3] | Dysaesthesia; “changed skin sensation” | Postmarketing; common in the patient leaflet |
| Canadian Product Monograph, Table 3 [3] | Blood creatine phosphokinase increased | 7 mg 1.1%, 14 mg 1.4%, placebo 0% |
| All three documents [1][2][3] | Muscle or joint pain | Not listed |
Skin that hurts: the dysaesthesia entry
Dysaesthesia means an abnormal, often unpleasant sensation. The European summary groups paraesthesia (pins and needles), pain of the skin, sensitive skin and a burning skin sensation under this heading [2]. In the PIONEER PLUS trial these were reported by 2.1% on 25 mg and 5.2% on 50 mg; they were mild to moderate and most people recovered while continuing treatment. With 3, 7 and 14 mg, the strengths used in the US, there was no excess over comparators in the trials, though events have been reported after approval [2].
A 2026 analysis of the international VigiBase reporting database found semaglutide associated with dysaesthesia and burning skin sensations, more often at higher doses; in many cases the medicine was stopped and symptoms improved [4]. Reported cases cannot show how often this happens.
A muscle enzyme in the Canadian table
Creatine phosphokinase, also called creatine kinase, is a muscle enzyme; MedlinePlus lists it among the blood tests a clinician may order for unexplained muscle pain [7]. In the two placebo-controlled trials, a rise in it was recorded in 1.1% on 7 mg and 1.4% on 14 mg, and in no one on placebo [3]. The monograph does not say whether these people had muscle pain, how large the rises were, or whether they resolved, so this is a laboratory signal, not evidence that Rybelsus® causes aches.
What reviews of trials show for joints and gout
A 2026 meta-analysis of 43 randomised trials with 100,488 participants found no difference between GLP-1 medicines and comparators in reports of gout, rheumatoid arthritis, osteoarthritis, osteoporotic fracture, synovitis or slipped discs [5]. A 2024 network meta-analysis of 22 outcome trials found GLP-1 medicines had a neutral effect on gout risk [6]. Neither abstract separates oral semaglutide from other products, but both point away from a joint-damaging effect of the drug class.
How aches could still relate to the tablet
- Label-supported: dehydration. Vomiting and diarrhoea can lead to fluid loss and kidney injury [1], and MedlinePlus lists electrolyte imbalance, such as low potassium or calcium, among causes of muscle pain [7].
- Label-supported: low blood sugar. With insulin or a sulfonylurea, the Medication Guide lists weakness and shakiness among signs of hypoglycaemia [1], which can be mistaken for achiness.
- Unmeasured: eating less and losing weight change how the body is loaded and fuelled, but no Rybelsus® study has examined aches.
Common causes unrelated to semaglutide
MedlinePlus lists far more frequent reasons for aching muscles and joints [7][8]:
- Overuse, tension, strains and sprains, and unusual exertion.
- Other medicines, including statins for cholesterol and ACE inhibitors for blood pressure, both common in people with diabetes.
- Infections such as flu, and conditions such as fibromyalgia, lupus and polymyalgia rheumatica.
- Osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
What general sources suggest
For aches from overuse or minor injury, MedlinePlus describes rest, ice in the first one to three days and heat afterwards, gentle stretching, massage, enough sleep and stress reduction, and gradually rebuilt exercise [7]. For non-arthritic joint pain it describes rest balanced with exercise, warm baths and stretching [8]. It also mentions over-the-counter pain relievers; ask your pharmacist which one fits with Rybelsus® and your other medicines, and remember that other tablets have to wait 30 minutes after your morning dose [1].
If a burning or tender skin feeling appears, record where it is and how long it lasts, and mention it to your prescriber, since it is the one ache-like effect the labels do list [2][3].
Rybelsus® and Ozempic® are registered trademarks of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| Muscle pain with weakness or inability to move part of the body, shortness of breath or trouble swallowing | Emergency services | Emergency | MedlinePlus [7] |
| Muscle pain with passing much less urine, sudden weight gain or fluid retention | Emergency services | Emergency | MedlinePlus [7] |
| Muscle pain with vomiting, a very stiff neck or high fever | Emergency services | Emergency | MedlinePlus [7] |
| Muscle pain that began after starting or changing a medicine such as a statin | Your provider | Today | MedlinePlus [7] |
| Severe, unexplained muscle or joint pain, or swelling and redness around a sore area | Your provider | Today | MedlinePlus [7][8] |
| Muscle pain lasting more than 3 days, or joint pain lasting more than several days | Your provider | At your next appointment | MedlinePlus [7][8] |
| A burning, tingling or painful skin sensation | Mention it to your prescriber | At your next appointment | Rybelsus® EU summary [2] |
